Services and R&D tools

  1. Selection of human antibodies from phage display libraries
  2. Selection of binders and mimotopes from M13 and Lambda libraries displaying peptides, constrained peptides and protein domains
  3. Construction of customized phage display libraries from human and mouse immunized donors
  4. Monoclonal antibody production by hybridoma technology
  5. Proprietary nanoformulated Infliximab mRNA, modified to reduce inflammatory potential and increase half-life, suitable for in vitro/vivo models
  6. Nucleic acid-based drug candidates and nanoformulation (Nanoassembler Ignite)
  7. Production of lab-scale pre-clinical lots o
    • Identity and purity (chromatography, electrophoresis, endotoxin, protein conc, …)
    • Specificity (ELISA, cytofluorimetry, Tissue microarray and IHC, …)
    • Affinity (BiaCore and BLI)
    • Pharmacology (Cell assays, HCS Operetta, RealTime qPCR, Arrays, …)